We are live on
!
Find out more
AA
Alta Advisers Portfolio holdings
AUM
$276M
1-Year Est. Return
26.84%
This Fund
S&P 500
This Quarter
Est. Return
+5.66%
1 Year Est. Return
+26.84%
3 Year Est. Return
+78.95%
5 Year Est. Return
+85.66%
10 Year Est. Return
–
AUM
$219M
AUM Growth
+$11M
(+5.3%)
Cap. Flow
+$1.16M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
55.78%
Holding
449
New
50
Increased
29
Reduced
3
Closed
36
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$616K |
| 2 |
Royal Bank of Canada
RY
|
+$438K |
| 3 |
Honeywell
HON
|
+$309K |
| 4 |
Toronto Dominion Bank
TD
|
+$271K |
| 5 |
Shopify
SHOP
|
+$258K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.07M |
| 2 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.09M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$867K |
| 4 |
IDEX
IEX
|
+$101K |
| 5 |
Tyler Technologies
TYL
|
+$101K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.08% |
| 2 | Financials | 8.52% |
| 3 | Healthcare | 7.41% |
| 4 | Consumer Discretionary | 6.49% |
| 5 | Communication Services | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Boston Scientific
BSX
$67.6B
| $327K | 0.15% |
3,900
| – | – |
|
77
Lam Research
LRCX
$365B
| $326K | 0.15% |
4,000
| – | – |
|
|
MRSH
78
Marsh
MRSH
$87.5B
| $326K | 0.15% |
1,463
| – | – |
|
79
Vertex Pharmaceuticals
VRTX
$122B
| $326K | 0.15% |
700
| – | – |
|
80
Stryker
SYK
$129B
| $325K | 0.15% |
900
| – | – |
|
81
Analog Devices
ADI
$181B
| $322K | 0.15% |
1,400
| – | – |
|
82
Citigroup
C
$223B
| $319K | 0.15% |
5,100
| – | – |
|
83
Chubb
CB
$139B
| $317K | 0.14% |
1,100
| – | – |
|
84
Regeneron Pharmaceuticals
REGN
$69.9B
| $315K | 0.14% |
300
| – | – |
|
85
Medtronic
MDT
$108B
| $315K | 0.14% |
3,500
| – | – |
|
86
Elevance Health
ELV
$82.1B
| $312K | 0.14% |
600
| – | – |
|
87
Starbucks
SBUX
$118B
| $312K | 0.14% |
3,200
| – | – |
|
88
Micron Technology
MU
$1.02T
| $311K | 0.14% |
3,000
| – | – |
|
|
89
Honeywell
HON
$77.9B
| $310K | 0.14% |
+1,592
| New | +$309K |
|
90
KLA
KLAC
$266B
| $310K | 0.14% |
4,000
| – | – |
|
91
Palo Alto Networks
PANW
$259B
| $308K | 0.14% |
1,800
| – | – |
|
92
Automatic Data Processing
ADP
$102B
| $304K | 0.14% |
1,100
| – | – |
|
93
Gilead Sciences
GILD
$162B
| $302K | 0.14% |
3,600
| – | – |
|
94
Nike
NKE
$62.5B
| $301K | 0.14% |
3,400
| – | – |
|
|
95
Shopify
SHOP
$165B
| $300K | 0.14% |
+3,741
| New | +$258K |
|
96
Deere & Co
DE
$169B
| $292K | 0.13% |
700
| – | – |
|
97
Blackstone
BX
$106B
| $291K | 0.13% |
1,900
| – | – |
|
|
98
Toronto Dominion Bank
TD
$198B
| $291K | 0.13% |
+4,591
| New | +$271K |
|
|
FISV
99
Fiserv Inc
FISV
$27.9B
| $287K | 0.13% |
1,600
| – | – |
|
100
Bristol-Myers Squibb
BMY
$128B
| $285K | 0.13% |
5,500
| – | – |
|
Similar funds
EFP
TLA
MC
IIA
FCT
AWA
RCA
TAP
Alta Advisers's Q3 2024 Portfolio in Review
As of Q3 2024, Alta Advisers held 449 positions worth $219M, up 5.3% from $208M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Alta Advisers's Q3 2024 filing shows 50 new, 29 increased, 3 reduced and 36 closed positions. Its largest new stake was Royal Bank of Canada: 3,813 shares worth $476K. The largest sale was Vanguard S&P 500 ETF, an estimated $2.07M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
- Alta Advisers's largest Q3 2024 buy was Royal Bank of Canada: 3,813 shares worth $476K.
- Alta Advisers added most to Apple in Q3 2024, an estimated $616K increase.
- Alta Advisers's biggest Q3 2024 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.07M.
- Alta Advisers fully exited IDEX in Q3 2024, selling an estimated $101K.
- Alta Advisers's ten largest holdings make up 56% of its $219M portfolio in Q3 2024.
- Alta Advisers opened 50 new positions and closed 36 in Q3 2024.
- Alta Advisers's portfolio value rose 5.3% quarter-over-quarter to $219M.
Based on Alta Advisers's 13F filing for Q3 2024, filed 8 Nov 2024.